121 related articles for article (PubMed ID: 3373746)
1. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; problems on standardization of the appropriate time for the withdrawal of anti-ulcer agents].
Takemoto T; Yanai H
Nihon Rinsho; 1988 Jan; 46(1):133-9. PubMed ID: 3373746
[No Abstract] [Full Text] [Related]
2. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; combination therapy of inhibitors of attacking factors and synergistic drugs for protective factors in peptic ulcer--selection of drug combinations and clinical efficacy].
Sakai M
Nihon Rinsho; 1988 Jan; 46(1):124-32. PubMed ID: 3373745
[No Abstract] [Full Text] [Related]
3. [Current aspects of course treatment and secondary prevention of peptic ulcer].
Ryss ES
Klin Med (Mosk); 1990 Apr; 68(4):134-42. PubMed ID: 1973467
[No Abstract] [Full Text] [Related]
4. [Endoscopy observation of patients with conducted eradication therapy of Helicobacter pylori in gastric and duodenal ulcer].
Koval' AM; Nefedova EA; Pulik AV; Vyrova IuV
Voen Med Zh; 2006 Jul; 327(7):28-33. PubMed ID: 16977878
[No Abstract] [Full Text] [Related]
5. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; intermittent and long-term administration].
Sakai H; Oka H; Sakaguchi M
Nihon Rinsho; 1988 Jan; 46(1):114-8. PubMed ID: 2897481
[No Abstract] [Full Text] [Related]
6. Peptic ulcers in the elderly: unique features and management.
Freston MS; Freston JW
Geriatrics; 1990 Jan; 45(1):39-42, 45. PubMed ID: 2403956
[TBL] [Abstract][Full Text] [Related]
7. [Short-term intervention in ulcer and reflux. New acid blocker halves duration of therapy].
Einecke D
MMW Fortschr Med; 2000 Jul; 142(26-27):50-1. PubMed ID: 10929487
[No Abstract] [Full Text] [Related]
8. [Antirecurrence treatment of peptic ulcer].
Papikian MKh; Vaĭstukh SI; Kulabukhov VG
Ter Arkh; 1980; 52(7):118-21. PubMed ID: 6996196
[No Abstract] [Full Text] [Related]
9. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
Uemura N; Okamoto S; Mukai T; Yamaguchi S; Kaji M; Hrruma K; Sumii K; Kajiyama G
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S67-9. PubMed ID: 8574740
[TBL] [Abstract][Full Text] [Related]
10. [Long-term therapy of peptic ulcer].
Berndt H
Z Arztl Fortbild (Jena); 1992 Mar; 86(6):287-90. PubMed ID: 1590008
[No Abstract] [Full Text] [Related]
11. [Treatment of peptic ulcer with gastrozepin].
Grigor'ev PIa; Khar'kovskiĭ NN; Elina NA; El'tsova NB; Elisova NV
Sov Med; 1984; (1):48-51. PubMed ID: 6546622
[No Abstract] [Full Text] [Related]
12. [Anti-Helicobacter pylori therapy. Who should be treated, how, how long?].
Lux G
Fortschr Med; 1996 Aug; 114(22-23):273-5. PubMed ID: 8974961
[No Abstract] [Full Text] [Related]
13. [Drug administration schedule of anti-ulcer agents to prevent recurrence of peptic ulcer; administration of synergistic drugs for protective factors in peptic ulcer--criteria of drug selection according to clinical symptoms and administration methods].
Fukuchi S
Nihon Rinsho; 1988 Jan; 46(1):119-23. PubMed ID: 3373744
[No Abstract] [Full Text] [Related]
14. [Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Domschke W; Dettmer A; Fenner T; Gregor M; Hesse P; Holtmann G; van Husen N; Miederer SE; Schentke KU; Schütz E
Z Gastroenterol; 1995 Oct; 33(10):598-601. PubMed ID: 7502553
[No Abstract] [Full Text] [Related]
15. [Long-term therapy of gastroduodenal ulcer disease].
Hahn L
Z Arztl Fortbild (Jena); 1993; Suppl 1():1-3. PubMed ID: 7901947
[No Abstract] [Full Text] [Related]
16. [Gastroduodenal diseases associated with helicobacter pylori].
Grigor'ev PIa; Iakovenko EP
Klin Med (Mosk); 1998; 76(6):11-5. PubMed ID: 9693493
[No Abstract] [Full Text] [Related]
17. [Effects of Helicobacter pylori eradication therapy on the healing process of peptic ulcers].
Imaizumi H; Koizumi W; Nakai H; Tanabe S; Ohida M; Saigenji K
Nihon Rinsho; 1999 Jan; 57(1):167-72. PubMed ID: 10036957
[TBL] [Abstract][Full Text] [Related]
18. Some aspects of the critical evaluation of peptic ulcer therapy in patients.
Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T
Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220
[TBL] [Abstract][Full Text] [Related]
19. [Problems in the traditional pharmacotherapy and prevention of peptic ulcer].
Ryss ES
Ter Arkh; 1984; 56(9):106-10. PubMed ID: 6393409
[TBL] [Abstract][Full Text] [Related]
20. [Losek (omeprazole), a new therapeutic agent in the treatment of peptic ulcer and hyperacidity states].
Bulgakov SA
Klin Med (Mosk); 1995; 73(5):11-6. PubMed ID: 8815266
[No Abstract] [Full Text] [Related]
[Next] [New Search]
